A study presented at the American Heart Association meeting in Orlando, FL described 72 patients with mild to moderate high blood pressure who were injected with an experimental vaccine. The vaccine, known as CYT006-AngQb works by inhibiting angiotensin II, a molecule responsible for elevating blood pressure.